| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs)
|
Tiseo, Marcello
|
|
2017
|
104 |
C |
p. 24-30
7 p.
|
artikel
|
| 2 |
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)
|
Awad, Mark M.
|
|
2017
|
104 |
C |
p. 126-130
5 p.
|
artikel
|
| 3 |
A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group
|
Laurie, Scott A.
|
|
2017
|
104 |
C |
p. 65-69
5 p.
|
artikel
|
| 4 |
A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801)
|
Kawaguchi, Koji
|
|
2017
|
104 |
C |
p. 79-84
6 p.
|
artikel
|
| 5 |
Contents
|
|
|
2017
|
104 |
C |
p. v-vi
nvt p.
|
artikel
|
| 6 |
Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patients
|
Juan, Oscar
|
|
2017
|
104 |
C |
p. 131-133
3 p.
|
artikel
|
| 7 |
Different histological subtypes of peripheral lung cancer based on emphysema distribution in patients with both airflow limitation and CT-determined emphysema
|
Shin, Beomsu
|
|
2017
|
104 |
C |
p. 106-110
5 p.
|
artikel
|
| 8 |
Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters
|
Koh, Young Wha
|
|
2017
|
104 |
C |
p. 31-37
7 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2017
|
104 |
C |
p. iii-
1 p.
|
artikel
|
| 10 |
Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells
|
Sesumi, Yuichi
|
|
2017
|
104 |
C |
p. 85-90
6 p.
|
artikel
|
| 11 |
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
|
Wu, Yi-Long
|
|
2017
|
104 |
C |
p. 119-125
7 p.
|
artikel
|
| 12 |
Exosomes in lung cancer liquid biopsies: Two sides of the same coin?
|
Rolfo, Christian
|
|
2017
|
104 |
C |
p. 134-135
2 p.
|
artikel
|
| 13 |
Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib
|
Messaritakis, I.
|
|
2017
|
104 |
C |
p. 16-23
8 p.
|
artikel
|
| 14 |
High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer
|
Okuma, Yusuke
|
|
2017
|
104 |
C |
p. 1-6
6 p.
|
artikel
|
| 15 |
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry
|
Hida, Tomoyuki
|
|
2017
|
104 |
C |
p. 98-105
8 p.
|
artikel
|
| 16 |
Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study
|
Awan, Sarah
|
|
2017
|
104 |
C |
p. 75-78
4 p.
|
artikel
|
| 17 |
Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer
|
Paz-Ares, Luis G.
|
|
2017
|
104 |
C |
p. 45-51
7 p.
|
artikel
|
| 18 |
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
|
Kato, Terufumi
|
|
2017
|
104 |
C |
p. 111-118
8 p.
|
artikel
|
| 19 |
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)
|
Lam, Vincent K.
|
|
2017
|
104 |
C |
p. 52-57
6 p.
|
artikel
|
| 20 |
Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion
|
Sakaguchi, Hirozo
|
|
2017
|
104 |
C |
p. 70-74
5 p.
|
artikel
|
| 21 |
Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study
|
Chang, Gee-Chen
|
|
2017
|
104 |
C |
p. 58-64
7 p.
|
artikel
|
| 22 |
The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma
|
Takada, Kazuki
|
|
2017
|
104 |
C |
p. 7-15
9 p.
|
artikel
|
| 23 |
The prognostic impact of tumor volume on stage I non-small cell lung cancer
|
Su, Xiao-Dong
|
|
2017
|
104 |
C |
p. 91-97
7 p.
|
artikel
|
| 24 |
What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration
|
Lillie, Sarah E.
|
|
2017
|
104 |
C |
p. 38-44
7 p.
|
artikel
|
Tijdschrift beschrijving